Acute effects of ethanol on the transfer of nicotine and two dietary carcinogens in human placental perfusion

Toxicology Letters

Volumn 205, Issue 3, 2011, Pages 257-264

  Veid, Jenni ^a   Karttunen, Vesa ^a   Myöhänen, Kirsi ^a   Myllynen, Päivi ^b   Auriola, Seppo ^a   Halonen, Toivo ^a   Vähäkangas, Kirsi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Fetal exposure; Food carcinogens; NDMA; Nicotine; PhIP; Toxicokinetics

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO(4,5 B)PYRIDINE; ALCOHOL; BREAST CANCER RESISTANCE PROTEIN; CARCINOGEN; N METHYL DEXTRO ASPARTIC ACID; NICOTINE; PHENAZONE; TOXIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; DIETARY INTAKE; DIFFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA PERFUSION; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADENOCARCINOMA; ANTIPYRINE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CARBON RADIOISOTOPES; CARCINOGENS; CELL LINE, TUMOR; DIFFUSION; DIMETHYLNITROSAMINE; ETHANOL; FEMALE; FOOD CONTAMINATION; HUMANS; IMIDAZOLES; INDICATORS AND REAGENTS; KINETICS; NEOPLASM PROTEINS; NICOTINE; PERFUSION; PLACENTA; PREGNANCY;

EID: 79960915544     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.06.014     Document Type: Article

References (61)

1. Anderson L.M., Hagiwara A., Kovatch R.M., Rehm S., Rice J.M. Transplacental initiation of liver, lung, neurogenic, and connective tissue tumors by N-nitroso compounds in mice. Fundam. Appl. Toxicol. 1989, 12:604-620.
2. Annola K., Heikkinen A.T., Partanen H., Woodhouse H., Segerbäck D., Vähäkangas K. Transplacental transfer of nitrosodimethylamine in perfused human placenta. Placenta 2009, 30:277-283.
3. Annola K., Karttunen V., Keski-Rahkonen P., Myllynen P., Segerback D., Heinonen S., Vahakangas K. Transplacental transfer of acrylamide and glycidamide are comparable to that of anripyrine in perfused human placenta. Toxicol. Lett. 2008, 182:50-56.
4. Arias H.R., Richards V.E., Ng D., Ghafoori M.E., Le V., Mousa S.A. Role of non-neural nicotinic acetylcholine receptors in angiogenesis. Int. J. Biochem. Cell Biol. 2009, 41:1141-1451.
5. Banakar M.K., Kudlur N.S., George S. Fetal alcohol spectrum disorder (FASD). Indian J. Pediatr. 2009, 76:1173-1175.
6. Barry J.A., Gawrisch K. Effects of ethanol on lipid bilayers containing cholesterol, gangliosides, and sphingomyelin. Biochemistry 1995, 34:8852-8860.
7. Beebe L.E., Kim Y.E., Amin S., Riggs C.W., Kovatch R.M., Anderson L.M. Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254). Carcinogenesis 1993, 14:1545-1548.
8. Brandes J.M., Tavoloni N., Potter B.J., Sarkozi L., Shepard M.D., Berk P.D. A new recycling technique for human placental cotyledon perfusion: Application to studies of fetomaternal transfer of glucose, inulin, and antipyrine. Am. J. Obstet. Gynecol. 1983, 146:800-806.
9. Brien J.F., Loomis C.W., Tranmer J., McGrath M. Disposition of ethanol in maternal venous blood and amniotic fluid. Am. J. Obstet. Gynecol. 1983, 146:181-186.
10. Catassi A., Servent D., Paleari L., Cesario A., Russo P. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat. Res. 2008, 659:221-231.
11. Chhabra S.K., Souliotis V.L., Harbaugh J.W., Krasnow S.W., Jones A.B., Anderson L.M., Kyrtopoulos S.A. O6-methylguanine DNA adduct formation and modulation by ethanol in placenta and fetal tissues after exposure of pregnant patas monkeys to N-nitrosodimethylamine. Cancer Res. 1995, 55:6017-6020.
12. Challier J.C., DóAthis P., Guerre-Millo M., Nandakumaran M. Flow-dependent transfer of antipyrine in the human placenta in vitro. Reprod. Nutr. Dev. 1983, 23:41-50.
13. Clarke D.W., Steenaart N.A., Breedon T.H., Brien J.F. Differential pharmacokinetics for oral and intraperitoneal administration of ethanol to the pregnant guinea pig. Can. J. Physiol. Pharmacol. 1985, 63:169-172.
14. Cumming M.E., Ong B.Y., Wade J.R., Sitar D.R. Maternal and fetal pharmacokinetics and cardiovascular responses in near-term pregnant sheep. Can. J. Physiol. Pharmacol. 1984, 62:1435-1439.
15. Davis R., Rizwani W., Banerjee S., Kovacs M., Haura E., Coppola D., Chellappan S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 2009, 4:e7524.
16. Disney E.R., Lacono W., McGue M., Tully E., Legrand L. Strengthening the case: prenatal alcohol exposure is associated with increased risk for conduct disorder. Pediatrics 2008, 122:1225-1230.
17. Egleton R., Brown K.C., Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol. Sci. 2008, 29:151-158.
18. Felton J., Knize M., Bennett M. Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. Toxicology 2004, 198:135-145.
19. Felton J., Knize M., Shen N., Andresen B., Bjeldanes L., Hatch F. Identification of the mutagens in cooked beef. Environ. Health Perspect. 1986, 67:17-24.
20. Floyd L., Sidhu J. Monitoring prenatal alcohol exposure. Am. J. Med. Genet. C: Semin. Med. Genet. 2004, 127C:3-9.
21. Fokina V.M., Patrikeeva S.L., Zharikova O.L., Nanovskaya T.N., Hankins G.V., Ahmed M.S. Transplacental transfer and metabolism of buprenorphine in preterm human placenta. Am. J. Perinatol. 2011, 28:25-32.
22. Frischknecht A.L., Frink L.J. Alcohols reduce lateral membrane pressures: predictions from molecular theory. Biophys. J. 2006, 91:4081-4090.
23. Guan J., Mao C., Xu F., Zhu L., Liu Y., Geng C., Zhang L., Xu Z. Low doses of nicotine-induced cardiovascular responses, hypoxia, and brain cellular activation in ovine fetuses. Neurotoxicology 2009, 30:290-297.
24. Hahnova-Cygalova L., Ceckova M., Staud F. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy. Drug Metab. Rev. 2011, 43:53-68.
25. Houezec J.L. Nicotine: abused substance and therapeutic agent. J. Psychiatry Neurosci. 1998, 23:95-108.
26. IARC, 1978. Monographs on the evaluation of the carcinogenic risk of chemicals to humans: some N-nitroso compounds. International Agency for Research on Cancer, Lyon.
27. IARC, 1988. Monographs, Alcohol drinking, Volume 44.
28. Idänpäan-Heikkilä J.E., Fritchie G.E., Ho B.T., McIsaac W.M. Placental transfer of C14-ethanol. Am. J. Obstet. Gynecol. 1971, 110:426-428.
29. Idänpään-Heikkilä J., Jouppila P., Åkerblom H.K., Isoaho R., Kauppila E., Koivisto M. Elimination and metabolic effects of ethanol in mother, fetus and newborn infant. Am. J. Obstet. Gynecol. 1972, 112:387-393.
30. Jones K.L., Smith D.W., Hanson J.W. The fetal alcohol syndrome: clinical delineation. Ann. N. Y. Acad. Sci. 1976, 273:130-139.
31. Jonker J.W., Buitelaar M., Wagenaar E., Van Der Valk M.A., Scheffer G.L., Scheper R.J., Plosch T., Kuipers F., Elferink R.P., Rosing H., Beijnen J.H., Schinkel A.H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U.S.A. 2002, 26:15649-15654.
32. Karttunen V., Myllynen P., Prochazka G., Pelkonen O., Segerbäck D., Vähäkangas K. Placental transfer and DNA binding of benzo(a)pyrene in human placental perfusion. Toxicol. Lett. 2010, 197:75-81.
33. May P.A., Gossage J.P., Kalberg W.O., Robinson L.K., Buckley D., Manning M., Hoyme H.E. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev. Disabil. Res. Rev. 2009, 15:176-192.
34. Mørck T.J., Sorda G., Bechi N., Rasmussen B.S., Nielsen J.B., Ietta F., Rytting E., Mathiesen L., Paulesu L., Knudsen L.E. Placental transport and in vitro effects of bisphenol A. Reprod. Toxicol. 2010, 30:131-137.
35. Mousa S., Mousa S.A. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J. Cell. Biochem. 2006, 97:1370-1378.
36. Myllynen P., Kummu M., Kangas T., Ilves M., Immonen E., Rysä J., Pirilä R., Lastumäki A., Vähäkangas K.H. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol. Appl. Pharmacol. 2008, 232:210-217.
37. Myllynen P., Pasanen M., Pelkonen O. Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 2005, 26:361-371.
38. Myllynen P.K., Pienimäki P.K., Vähäkangas K.H. Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo. Eur. J. Clin. Pharmacol. 2003, 58:677-682.
39. Myllynen P., Mathiesen L., Weimer M., Annola K., Immonen E., Karttunen V., Kummu M., Mørck T.J., Nielsen J.K., Knudsen L.E., Vähäkangas K. Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reprod. Toxicol. 2010, 30:94-102.
40. Myren M., Mose T., Mathiasen L., Knudsen L. The human placenta-an alternative for studying foetal exposure. Toxicol. In Vitro 2007, 21:1332-1340.
41. Nanovskaya T.N., Nekhayeva I.A., Hankings G.D.V., Ahmed M.A. Transfer of methadone across the dually perfused preterm human placental lobule. Am. J. Obstet. Gynecol. 2008, 198. 126.e1-126.e4.
42. Pajulo M., Savonlahti E., Sourander A., Helenius H., Piha J. Antenatal depression, substrate dependency and social support. J. Affect. Disord. 2001, 65:9-17.
43. Panigel M. Placental perfusion experiments. Am. J. Obstet. Gynecol. 1962, 84:1664-1683.
44. Partanen H.A., El-Nezami H.S., Leppänen J.M., Myllynen P.K., Woodhouse H.J., Vähäkangas K.H. Aflatoxin B1 transfer and metabolism in human placenta. Toxicol. Sci. 2010, 113:216-225.
45. Patra M., Salonen E., Terama E., Vattulainen I., Faller R., Lee B.W., Holopainen J., Karttunen M. Under the influence of alcohol: the effect of ethanol and methanol on lipid bilayers. Biophys. J. 2006, 90:1121-1135.
46. Pegg A.E. Metabolism of N-Nitrosodimethylamine 1980, IARC Scientific Publications, pp. 3-22.
47. Perera F., Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod. Toxicol. 2011, 31:363-373.
48. Pesonen A.K., Räikkönen K., Matthews K., Heinonen K., Paavonen J.E., Lahti J., Komsi N., Lemola S., Järvenpää A.L., Kajantie E., Strandberg T. Prenatal origins of poor sleep in children. Sleep 2009, 32:1086-1092.
49. Petrovic V., Wang J.H., Piquette-Miller M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats.Drug Metab. Dispos. 2008, 36:1944-1950.
50. Pienimäki P., Hartikainen A.L., Arvela P., Partanen T., Herva R., Pelkonen O., Vähäkangas K. Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia 1995, 36:241-248.
51. Raunio H., Pokela N., Puhakainen K., Rahnasto M., Mauriala T., Auriola S., Juvonen R.O. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Xenobiotica 2008, 38:34-47.
52. Schneider H., Panigel M., Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am. J. Obstet. Gynecol. 1972, 114:822-828.
53. Senecky Y., Inbar D., Diamond G., Basel-Vanagaite L., Rigler S., Chodick G. Isr. Med. Assoc. J. 2009, 11:619-622.
54. Sugimura T. Overview of carcinogenic heterocyclic amines. Mutat. Res. 1997, 376:211-219.
55. Terama E., Ollila O.H., Salonen E., Rowat A.C., Trandum C., Westh P., Patra M., Karttunen M., Vattulainen I. Influence of ethanol on lipid membranes: from lateral pressure profiles to dynamics and partitioning. J. Phys. Chem. B 2008, 112:4131-4139.
56. Vähäkangas K., Myllynen P. Drug transporters in the human blood-placental barrier. Br. J. Pharmacol. 2009, 158:665-678.
57. Vähäkangas K.H., Veid J., Karttunen V., Partanen H., Sieppi E., Kummu M., Myllynen P., Loikkanen J. The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics. Reproductive and developmental toxicology. 2011, 1051-1065. Elsevier Inc, United States of America. 1st ed. R. Gupta (Ed.).
58. West J., Blake C. Fetal alcohol syndrome: an assessment of the field. Exp. Biol. Med. 2005, 230:354-356.
59. Wogan G.N., Tannenbaum S.R. Environmental N-nitroso compounds: implications for public health. Toxicol. Appl. 1975, 31:375-383.
60. Yang C.S., Ishizaki H., Lee M.J., Wade D., Fadel A. Deuterium isotope effect in the interaction of N-nitrosodimethylamine, ethanol, and related compounds with cytochrome P-450IIE1. Chem. Res. Toxicol. 1991, 4:408-413.
61. Yeboah D., Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., Gibb W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol. 2006, 84:1251-1258.